Pulse Biosciences Files 8-K on Financials
Ticker: PLSE · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1625101
| Field | Detail |
|---|---|
| Company | Pulse Biosciences, Inc. (PLSE) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
TL;DR
Pulse Biosciences dropped an 8-K on financials - check it for the latest numbers.
AI Summary
Pulse Biosciences, Inc. filed an 8-K on March 28, 2025, reporting on its results of operations and financial condition as of March 27, 2025. The filing includes financial statements and exhibits, with no specific dollar amounts or significant events detailed in the provided text.
Why It Matters
This filing provides an update on Pulse Biosciences' financial condition and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification without specific material events or financial figures that would indicate high risk.
Key Players & Entities
- PULSE BIOSCIENCES, INC. (company) — Registrant
- March 27, 2025 (date) — Date of Earliest Event Reported
- March 28, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 46-5696597 (identifier) — IRS Employer Identification No.
- 601 Brickell Key Drive, Suite 1000 (address) — Principal Executive Offices
- Miami (location) — City of Principal Executive Offices
- Florida (location) — State of Principal Executive Offices
- 33131 (zip_code) — Zip Code of Principal Executive Offices
- 510 - 906-4600 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Pulse Biosciences, Inc.'s Results of Operations and Financial Condition, along with Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on March 28, 2025.
What is the earliest event date reported in this filing?
The earliest event date reported in this filing is March 27, 2025.
Where is Pulse Biosciences, Inc. incorporated?
Pulse Biosciences, Inc. is incorporated in Delaware.
What is the principal executive office address for Pulse Biosciences, Inc.?
The principal executive office address for Pulse Biosciences, Inc. is 601 Brickell Key Drive, Suite 1000, Miami, Florida 33131.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding PULSE BIOSCIENCES, INC. (PLSE).